Figure 1From: Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study Scatter plot of changes in body weight and HbA1c from baseline to 1 year after liraglutide introduction. Back to article page